Polymyxin B-Induced Skin Hyperpigmentation

Polymyxin B-Induced Skin Hyperpigmentation

Polymyxin B-induced skin hyperpigmentation is a rare adverse drug reaction (ADR). In this report, we present the case of a patient who underwent an abscess resection with right epididymitis, in which a multidrug-resistant Klebsiella pneumoniae infection (KPI) is formed. The patient was treated with...

Full description

Bibliographic Details
Main Authors: Xueke Wen, Chunliu Luo, Weitao Lyu
Format: Article
Language:English
Published: Hindawi Limited 2020-01-01
Series:Case Reports in Medicine
Online Access:http://dx.doi.org/10.1155/2020/6461329
id doaj-6dcd344fee214caf9c15fb3dadc4eb1b
record_format Article
spelling doaj-6dcd344fee214caf9c15fb3dadc4eb1b2020-11-25T03:52:49ZengHindawi LimitedCase Reports in Medicine1687-96271687-96352020-01-01202010.1155/2020/64613296461329Polymyxin B-Induced Skin HyperpigmentationXueke Wen0Chunliu Luo1Weitao Lyu2The First Clinical Medical College of Jinan University, No. 601 Huangpu Avenue West, Guangzhou City 510630, Guangdong Province, ChinaThe First Affiliated Hospital of Jinan University, No. 613 Huangpu Avenue West, Guangzhou City 510630, Guangdong Province, ChinaThe First Affiliated Hospital of Jinan University, No. 613 Huangpu Avenue West, Guangzhou City 510630, Guangdong Province, ChinaPolymyxin B-induced skin hyperpigmentation is a rare adverse drug reaction (ADR). In this report, we present the case of a patient who underwent an abscess resection with right epididymitis, in which a multidrug-resistant Klebsiella pneumoniae infection (KPI) is formed. The patient was treated with polymyxin B and subsequently developed skin hyperpigmentation and desquamation. The desquamation improved and the pigmentation gradually returned to normal after sixty days after the withdrawal of polymyxin B.http://dx.doi.org/10.1155/2020/6461329
collection DOAJ
language English
format Article
sources DOAJ
author Xueke Wen
Chunliu Luo
Weitao Lyu
spellingShingle Xueke Wen
Chunliu Luo
Weitao Lyu
Polymyxin B-Induced Skin Hyperpigmentation
Case Reports in Medicine
author_facet Xueke Wen
Chunliu Luo
Weitao Lyu
author_sort Xueke Wen
title Polymyxin B-Induced Skin Hyperpigmentation
title_short Polymyxin B-Induced Skin Hyperpigmentation
title_full Polymyxin B-Induced Skin Hyperpigmentation
title_fullStr Polymyxin B-Induced Skin Hyperpigmentation
title_full_unstemmed Polymyxin B-Induced Skin Hyperpigmentation
title_sort polymyxin b-induced skin hyperpigmentation
publisher Hindawi Limited
series Case Reports in Medicine
issn 1687-9627
1687-9635
publishDate 2020-01-01
description Polymyxin B-induced skin hyperpigmentation is a rare adverse drug reaction (ADR). In this report, we present the case of a patient who underwent an abscess resection with right epididymitis, in which a multidrug-resistant Klebsiella pneumoniae infection (KPI) is formed. The patient was treated with polymyxin B and subsequently developed skin hyperpigmentation and desquamation. The desquamation improved and the pigmentation gradually returned to normal after sixty days after the withdrawal of polymyxin B.
url http://dx.doi.org/10.1155/2020/6461329
work_keys_str_mv AT xuekewen polymyxinbinducedskinhyperpigmentation
AT chunliuluo polymyxinbinducedskinhyperpigmentation
AT weitaolyu polymyxinbinducedskinhyperpigmentation
_version_ 1715096627704758272

Similar Items